Marco de Bruyn Selected Research

rimcazole

9/2013	In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imaging.
11/2010	Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco de Bruyn Research Topics

Disease

29	Neoplasms (Cancer) 04/2022 - 08/2008
3	Endometrial Neoplasms (Endometrial Cancer) 10/2020 - 07/2015
3	Melanoma (Melanoma, Malignant) 09/2013 - 11/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 10/2018 - 11/2016
2	Colorectal Neoplasms (Colorectal Cancer) 11/2016 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2015 - 04/2014
2	Rheumatoid Arthritis 09/2014 - 01/2011
2	Infections 06/2013 - 12/2008
1	Rupture 01/2022
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Injection Site Reaction 01/2021
1	Bites and Stings (Sting) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Tertiary Lymphoid Structures 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Ovarian Epithelial Carcinoma 10/2018
1	Carcinosarcoma 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Multiple Sclerosis 09/2014
1	B-Cell Leukemia (Leukemia, B Cell) 04/2014
1	Asthma (Bronchial Asthma) 06/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2011
1	Ischemia 05/2010
1	Reperfusion Injury 05/2010

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
5	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2016
5	Immunoglobulin FragmentsIBA 04/2014 - 08/2008
4	LigandsIBA 09/2013 - 08/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2020
3	AntibodiesIBA 05/2021 - 01/2011
3	AntigensIBA 01/2021 - 02/2016
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
2	Therapeutic UsesIBA 04/2022 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	VaccinesIBA 01/2021 - 10/2018
2	Exonucleases (3' 5' Exonuclease)IBA 10/2020 - 07/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2015 - 08/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 08/2008
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2015 - 12/2008
2	rimcazoleIBA 09/2013 - 11/2010
1	Pharmaceutical PreparationsIBA 01/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	InterferonsIBA 01/2021
1	ametantrone (HAQ)IBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Chemokine CXCL13IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	DNA Polymerase IIIBA 11/2016
1	CytokinesIBA 11/2016
1	Granzymes (Granzyme)IBA 07/2015
1	DNA replicaseIBA 07/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Complement System Proteins (Complement)IBA 01/2015
1	Galectins (Galectin)IBA 01/2015
1	CalreticulinIBA 01/2015
1	InterleukinsIBA 09/2014
1	Interleukin-17 (Interleukin 17)IBA 09/2014
1	Biological ProductsIBA 09/2014
1	CD40 Ligand (CD40L)IBA 04/2014
1	Epithelial Cell Adhesion MoleculeIBA 04/2014
1	Glucose (Dextrose)FDA LinkGeneric 09/2013
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2013
1	LectinsIBA 06/2013
1	Immunotoxins (Immunotoxin)IBA 05/2013
1	Surface Antigens (Surface Antigen)IBA 05/2013
1	Death Domain ReceptorsIBA 05/2013
1	Carrier Proteins (Binding Protein)IBA 09/2012
1	Polysaccharides (Glycans)IBA 09/2012
1	Chondroitin Sulfate ProteoglycansIBA 11/2010
1	tricarbonyldichlororuthenium (II) dimerIBA 05/2010
1	Recombinant Fusion ProteinsIBA 12/2008
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 08/2008

Therapy/Procedure

15	Therapeutics 01/2022 - 11/2010
10	Immunotherapy 04/2022 - 11/2010
3	Drug Therapy (Chemotherapy) 10/2020 - 01/2015
1	Radiotherapy 10/2020
1	Adjuvant Chemotherapy 10/2020
1	Adjuvant Chemoradiotherapy 10/2020
1	Lymph Node Excision (Lymph Node Dissection) 01/2018
1	Surgical Instruments (Clip) 05/2010
1	Intraocular Injections 12/2008